TrialDiabetes, obesity & metabolism2020

Efficacy and safety of MYL-1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study.

Thomas C Blevins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.